Treatment

The study will be conducted as a prospective, cohort study across 13 UK sites. Participants will be recruited from two i clinical trials

1 indexed studies · 0 currently recruiting

Not yet recruiting
The National Unified Renal Translational Research Enterprise for biosampling patients with rare kidney disease
This study collects samples and health details from children aged 0-16 with rare kidney diseases like glomerulonephritis, and healthy children. Researchers hope to better understand these conditions, find early signs of problems, and develop improved, personalised treatments by studying blood, urine, and medical records.
For: Children and young people with rare kidney diseases. Glomerulonephritis (GN): Including subtypes such as IgA Vasculitis Nephritis (IgAVN), IgA Nephropathy (IgAN), Idiopathic Nephrotic Syndrome (iNS), C3 Glomerulopathy/Membranoproliferative GN (MPGN), Post-infectious Glomerulonephritis (PIGN), Lupus Nephritis (LN), ANCA-associated vasculitis (AAV), and Membranous Nephropathy (MN)
United Kingdom · England · Northern Ireland